BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22149143)

  • 1. Pilot studies for development of an HIV subtype panel for surveillance of global diversity.
    Manak M; Sina S; Anekella B; Hewlett I; Sanders-Buell E; Ragupathy V; Kim J; Vermeulen M; Stramer SL; Sabino E; Grabarczyk P; Michael N; Peel S; Garrett P; Tovanabutra S; Busch MP; Schito M
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):594-606. PubMed ID: 22149143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.
    Sanchez AM; DeMarco CT; Hora B; Keinonen S; Chen Y; Brinkley C; Stone M; Tobler L; Keating S; Schito M; Busch MP; Gao F; Denny TN
    J Immunol Methods; 2014 Jul; 409():117-30. PubMed ID: 24447533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of HIV-1 isolates from Brazil reveals presence of two distinct genetic subtypes.
    Louwagie J; Delwart EL; Mullins JI; McCutchan FE; Eddy G; Burke DS
    AIDS Res Hum Retroviruses; 1994 May; 10(5):561-7. PubMed ID: 7917518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic and genetic characterization of a panel of 60 human immunodeficiency virus type 1 isolates, representing clades A, B, C, D, CRF01_AE, and CRF02_AG, for the development and assessment of candidate vaccines.
    Brown BK; Darden JM; Tovanabutra S; Oblander T; Frost J; Sanders-Buell E; de Souza MS; Birx DL; McCutchan FE; Polonis VR
    J Virol; 2005 May; 79(10):6089-101. PubMed ID: 15857994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of an HIV-1 Subtype Panel in China: Isolation and Characterization of 30 HIV-1 Primary Strains Circulating in China.
    Han J; Liu S; Guo W; Bao Z; Wang X; Li L; Liu Y; Zhuang D; Li H; Jia L; Gui T; Sui H; Li T; Li J
    PLoS One; 2015; 10(5):e0127696. PubMed ID: 26018591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda.
    Brennan CA; Lund JK; Golden A; Yamaguchi J; Vallari AS; Phillips JF; Kataaha PK; Jackson JB; Devare SG
    AIDS; 1997 Dec; 11(15):1823-32. PubMed ID: 9412700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of HIV-1 subtypes: implications for vaccine formulations.
    Smith TL; van Rensburg EJ; Engelbrecht S
    J Med Virol; 1998 Nov; 56(3):264-8. PubMed ID: 9783696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research.
    Wieczorek L; Krebs SJ; Kalyanaraman V; Whitney S; Tovanabutra S; Moscoso CG; Sanders-Buell E; Williams C; Slike B; Molnar S; Dussupt V; Alam SM; Chenine AL; Tong T; Hill EL; Liao HX; Hoelscher M; Maboko L; Zolla-Pazner S; Haynes BF; Pensiero M; McCutchan F; Malek-Salehi S; Cheng RH; Robb ML; VanCott T; Michael NL; Marovich MA; Alving CR; Matyas GR; Rao M; Polonis VR
    J Virol; 2015 Aug; 89(15):7478-93. PubMed ID: 25972551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C.
    Salminen MO; Johansson B; Sönnerborg A; Ayehunie S; Gotte D; Leinikki P; Burke DS; McCutchan FE
    AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1329-39. PubMed ID: 8891112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection.
    Wratil PR; Rabenau HF; Eberle J; Stern M; Münchhoff M; Friedrichs I; Stürmer M; Berger A; Kuttner-May S; Münstermann D; Lucht A; Meixenberger K; Bannert N; Keppler OT
    Med Microbiol Immunol; 2020 Apr; 209(2):139-150. PubMed ID: 32036450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.
    Devito C; Levi M; Hinkula J; Fernandez Medina RD; Libonatti O; Wigzell H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):156-9. PubMed ID: 9473017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay.
    Keating SM; Rountree W; Grebe E; Pappas AL; Stone M; Hampton D; Todd CA; Poniewierski MS; Sanchez A; Porth CG; Denny TN; Busch MP;
    PLoS One; 2019; 14(9):e0222290. PubMed ID: 31525218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
    Gao F; Morrison SG; Robertson DL; Thornton CL; Craig S; Karlsson G; Sodroski J; Morgado M; Galvao-Castro B; von Briesen H; Beddows S; Weber J; Sharp PM; Shaw GM; Hahn BH
    J Virol; 1996 Mar; 70(3):1651-67. PubMed ID: 8627686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
    Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
    J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on HIV-1 diversity in Africa: a decade in review.
    Lihana RW; Ssemwanga D; Abimiku A; Ndembi N
    AIDS Rev; 2012; 14(2):83-100. PubMed ID: 22627605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
    Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
    Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa.
    van Harmelen J; Wood R; Lambrick M; Rybicki EP; Williamson AL; Williamson C
    AIDS; 1997 Jan; 11(1):81-7. PubMed ID: 9110079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
    Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
    Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of four laboratory approaches for cross-sectional HIV incidence determination: analysis of samples from adults with known nonrecent HIV infection from five African countries.
    Laeyendecker O; Brookmeyer R; Mullis CE; Donnell D; Lingappa J; Celum C; Baeten JM; Campbell MS; Essex M; de Bruyn G; Farquhar C; Quinn TC; Eshleman SH;
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1177-83. PubMed ID: 22283149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.